Sonus decides against merger

  • By Eric Fetters / Herald Writer
  • Tuesday, March 15, 2005 9:00pm
  • Business

BOTHELL – Sonus Pharmaceuticals has canceled its takeover of a small French biotechnology company, deciding instead to focus on gaining approval for its chemotherapy drug.

The Bothell-based company announced its intention in November to buy Synt:em, a privately held company in Nimes, France.

Synt:em has worked with peptides, special proteins that can improve the way a drug targets the part of the body it is meant to treat. The company, which like Sonus employs about 40 people, has early-stage drug candidates that could help treat cancers and control pain.

That seemed to fit well with Sonus’ focus on targeted anti-cancer drugs and related therapies.

But Michael Martino, Sonus’ president and chief executive, said Tuesday that the acquisition would have been too much of a distraction and a potential drain on resources at a critical time for the company.

“We concluded that the required focus of our resources is best achieved as a stand-alone company at this time,” Martino said in a written statement. He added he still has high regard for Synt:em.

Sonus hopes to begin the final steps later this year toward receiving U.S. Food and Drug Administration approval for Tocosol paclitaxel. Tocosol, the firm’s most advanced product, belongs to the family of taxane-based treatments, the most widely used chemotherapy drugs in the world.

If the deal with Synt:em – originally valued at $30 million – had gone through, it was scheduled to be completed by the end of this month.

Late in 2004, the two companies revised the proposed terms of Sonus’ acquisition, reducing the number of shares Sonus would issue in the all-stock deal from nearly 9 million to 5.4 million. That would have allowed Synt:em’s shareholders to own 20 percent of the combined company.

Reporter Eric Fetters: 425-339-3453 or fetters@heraldnet.com.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Business

Lily Lamoureux stacks Weebly Funko toys in preparation for Funko Friday at Funko Field in Everett on July 12, 2019.  Kevin Clark / The Herald)
Everett-based Funko ousts its CEO after 14 months

The company, known for its toy figures based on pop culture, named Michael Lunsford as its interim CEO.

The livery on a Boeing plane. (Christopher Pike / Bloomberg)
Former Lockheed Martin CFO joins Boeing as top financial officer

Boeing’s Chief Financial Officer is being replaced by a former CFO at… Continue reading

Izaac Escalante-Alvarez unpacks a new milling machine at the new Boeing machinists union’s apprentice training center on Friday, June 6, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Boeing Machinists union training center opens in Everett

The new center aims to give workers an inside track at Boeing jobs.

Some SnoCo stores see shortages after cyberattack on grocery supplier

Some stores, such as Whole Foods and US Foods CHEF’STORE, informed customers that some items may be temporarily unavailable.

People take photos and videos as the first Frontier Arlines flight arrives at Paine Field Airport under a water cannon salute on Monday, June 2, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Water cannons salute Frontier on its first day at Paine Field

Frontier Airlines joins Alaska Airlines in offering service Snohomish County passengers.

Amit B. Singh, president of Edmonds Community College. 201008
Edmonds College and schools continue diversity programs

Educational diversity programs are alive and well in Snohomish County.

A standard jet fuel, left, burns with extensive smoke output while a 50 percent SAF drop-in jet fuel, right, puts off less smoke during a demonstration of the difference in fuel emissions on Tuesday, March 28, 2023 in Everett, Washington. (Olivia Vanni / The Herald)
Sustainable aviation fuel center gets funding boost

A planned research and development center focused on sustainable aviation… Continue reading

Helion's 6th fusion prototype, Trenta, on display on Tuesday, July 9, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Helion celebrates smoother path to fusion energy site approval

Helion CEO applauds legislation signed by Gov. Bob Ferguson expected to streamline site selection process.

Pharmacist John Sontra and other employees work on calling customers to get their prescriptions transferred to other stores from the Bartell Drugs Pharmacy on Hoyt Avenue on Wednesday, July 2, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Bartell Drugs location shutters doors in Everett

John Sontra, a pharmacist at the Hoyt Avenue address for 46 years, said Monday’s closure was emotional.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.